RNAi probes targeting cancer-related proteins

Details for Australian Patent Application No. 2003258426 (hide)

Owner The University of British Columbia

Inventors Trougakos, Ioannis P.; Gleave, Martin E.; Beraldi, Eliana; Jansen, Burkhard; Signaevsky, Maxim; Gonos, Efstathios, S.

Agent Freehills

Pub. Number AU-B-2003258426

PCT Number PCT/CA03/01277

PCT Pub. Number WO2004/018676

Priority 60/408,152 03.09.02 US; 60/472,387 20.05.03 US; 60/405,193 21.08.02 US

Filing date 21 August 2003

Wipo publication date 11 March 2004

Acceptance publication date 10 April 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

13 November 2003 Complete Application Filed

  Priority application(s): 60/408,152 03.09.02 US; 60/472,387 20.05.03 US; 60/405,193 21.08.02 US

22 April 2004 Application Open to Public Inspection

  Published as AU-B-2003258426

10 April 2008 Application Accepted

  Published as AU-B-2003258426

7 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003258427-Electrode for photovoltaic cells, photovaltaic cell and photovoltaic module

2003258425-Treatment of melanoma by reduction in clusterin levels